Differentiated thyroid cancer patients who receive radioiodine (RAI) treatment after surgery have increased relative survival rates compared to those who do not receive the treatment. According to new ...

Five-year relative survival rates for all cancers combined have increased to 70% for people diagnosed during 2015 to 2021 in the United States, according to the "Cancer Statistics, 2026," report, ...

In this study, the researchers aimed to identify 5- and 10-year relative survival outcomes for individuals aged younger than 20 years at the time of a cancer diagnosis.

Papillary thyroid cancer (PTC) generally has a good prognosis, with 5-year relative survival rates of 99% for regional cancer that has spread to the lymph nodes. PTC is the most common type of thyroid ...

CLEVELAND, Ohio — Seven in 10 people now survive their cancer five years or longer, up from only half in the mid-1970s, according to a new report from the American Cancer Society. The five-year ...

Graphical Abstract. Relative survival with and without radioiodine therapy (RAI) in intermediate risk papillary thyroid cancer (PTC) and low risk, minimally invasive follicular thyroid cancer (FTC). A ...